216 related articles for article (PubMed ID: 37633277)
1. Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate.
Graboski AL; Kowalewski ME; Simpson JB; Cao X; Ha M; Zhang J; Walton WG; Flaherty DP; Redinbo MR
Cell Chem Biol; 2023 Nov; 30(11):1402-1413.e7. PubMed ID: 37633277
[TBL] [Abstract][Full Text] [Related]
2. Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota.
Devlin AS; Marcobal A; Dodd D; Nayfach S; Plummer N; Meyer T; Pollard KS; Sonnenburg JL; Fischbach MA
Cell Host Microbe; 2016 Dec; 20(6):709-715. PubMed ID: 27916477
[TBL] [Abstract][Full Text] [Related]
3. Microbial Modulation of a Uremic Toxin.
Skye SM; Hazen SL
Cell Host Microbe; 2016 Dec; 20(6):691-692. PubMed ID: 27978427
[TBL] [Abstract][Full Text] [Related]
4. Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production.
Wang Y; Li J; Chen C; Lu J; Yu J; Xu X; Peng Y; Zhang S; Jiang S; Guo J; Duan J
Gut Microbes; 2020 Nov; 12(1):1-19. PubMed ID: 33016221
[TBL] [Abstract][Full Text] [Related]
5. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
[TBL] [Abstract][Full Text] [Related]
6. Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate.
Niwa T; Ise M; Miyazaki T
Am J Nephrol; 1994; 14(3):207-12. PubMed ID: 7977482
[TBL] [Abstract][Full Text] [Related]
7. Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function.
Lobel L; Cao YG; Fenn K; Glickman JN; Garrett WS
Science; 2020 Sep; 369(6510):1518-1524. PubMed ID: 32943527
[TBL] [Abstract][Full Text] [Related]
8. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
[TBL] [Abstract][Full Text] [Related]
9. Indole and indoxyl sulfate, gut bacteria metabolites of tryptophan, change arterial blood pressure via peripheral and central mechanisms in rats.
Huć T; Nowinski A; Drapala A; Konopelski P; Ufnal M
Pharmacol Res; 2018 Apr; 130():172-179. PubMed ID: 29287686
[TBL] [Abstract][Full Text] [Related]
10. Microbe-derived uremic solutes enhance thrombosis potential in the host.
Nemet I; Funabashi M; Li XS; Dwidar M; Sangwan N; Skye SM; Romano KA; Cajka T; Needham BD; Mazmanian SK; Hajjar AM; Rey FE; Fiehn O; Tang WHW; Fischbach MA; Hazen SL
mBio; 2023 Nov; 14(6):e0133123. PubMed ID: 37947418
[No Abstract] [Full Text] [Related]
11. Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease.
Yang CY; Chen TW; Lu WL; Liang SS; Huang HD; Tseng CP; Tarng DC
Cells; 2021 Jan; 10(1):. PubMed ID: 33435396
[TBL] [Abstract][Full Text] [Related]
12. Uremic toxicity of indoxyl sulfate.
Niwa T
Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
[TBL] [Abstract][Full Text] [Related]
13. Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease.
Gao H; Liu S
Life Sci; 2017 Sep; 185():23-29. PubMed ID: 28754616
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients-A Randomized Trial.
Mitrović M; Stanković-Popović V; Tolinački M; Golić N; Soković Bajić S; Veljović K; Nastasijević B; Soldatović I; Svorcan P; Dimković N
J Ren Nutr; 2023 Mar; 33(2):278-288. PubMed ID: 35995418
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation.
Lu S; Zhao J; Chen X; Xu S; Yang X; Zhang Y; Ma Z; Jiang H; Zhou H
Chem Biol Interact; 2022 Dec; 368():110219. PubMed ID: 36243147
[TBL] [Abstract][Full Text] [Related]
16. Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins.
Chao CT; Lin SH
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371477
[TBL] [Abstract][Full Text] [Related]
17. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
[TBL] [Abstract][Full Text] [Related]
18. Targeting protein-bound uremic toxins in chronic kidney disease.
Niwa T
Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
[TBL] [Abstract][Full Text] [Related]
19. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
[TBL] [Abstract][Full Text] [Related]
20. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
